BCYC

Latest SEC Filings & News for BCYC

2 most recent filings and news items mentioning BCYC. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/BCYC/news?limit=20"

Pull BCYC filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Earnings|Guidance|LeadershipJul 30, 2026Neutral

Bicycle Therapeutics reports Q2 results, provides clinical updates

The company reported Q2 2026 financials with $510.1 million in cash, provided clinical update on nuzefatide during AACR, and expanded its Clinical Advisory Board.

View filing at SEC.gov →

RegulatoryMay 21, 2026Positive

Bicycle Therapeutics presents Phase 2 Duravelo-2 data showing comparable efficacy with improved safety

Zelenectide pevedotin combined with pembrolizumab demonstrated response rates comparable to standard of care in metastatic urothelial cancer with approximately four-fold lower skin reactions and half the peripheral neuropathy rates. The data validation of Bicycle's technology pla

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.